SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001447028-19-000015
Filing Date
2019-05-06
Accepted
2019-05-06 17:30:15
Documents
61
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q arbutusq12019.htm 10-Q 727597
2 EXHIBIT 10.1 exhibit101koertvandenenden.htm EX-10.1 24451
3 EXHIBIT 31.1 exhibit311q12019.htm EX-31.1 13497
4 EXHIBIT 31.2 exhibit312q12019.htm EX-31.2 13971
5 EXHIBIT 32.1 exhibit321q12019.htm EX-32.1 6598
6 EXHIBIT 32.2 exhibit322q12019.htm EX-32.2 6894
13 hbvpipelinenoexplanatorytext.jpg GRAPHIC 69216
  Complete submission text file 0001447028-19-000015.txt   4040572

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT abus-20190331.xml EX-101.INS 677585
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT abus-20190331.xsd EX-101.SCH 39383
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT abus-20190331_cal.xml EX-101.CAL 67305
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT abus-20190331_def.xml EX-101.DEF 134654
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT abus-20190331_lab.xml EX-101.LAB 474508
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT abus-20190331_pre.xml EX-101.PRE 259243
Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Filer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34949 | Film No.: 19800493
SIC: 2834 Pharmaceutical Preparations